Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is Fabre-Kramer’s Gepirone Antidepressant Rising From The Dead After 8 Years?

Sep 08 2015

• By Brenda Sandburg

Related Content

Fabre-Kramer/GSK Submit Gepirone ER For Major Depressive Disorder

May 08 2007

Third Strike For Gepirone ER: Fabre-Kramer/GSK Antidepressant “Not Approvable” Again

Nov 05 2007

Related Companies

Fabre-Kramer Pharmaceuticals

GSK plc

Merck & Co., Inc.

Bristol Myers Squibb Company

Schering-Plough

Merck & Co., Inc.

Additional Topics

United States Regulation Advisory Committees Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window